The new definition and diagnostic criteria of Parkinson's disease
Ronald B. Postuma(Montreal Neurological Institute and Hospital), Matthew Stern(Penn Center for AIDS Research), Irene Litvan(University of California, San Diego), Christopher G. Goetz(Rush University Medical Center), Charles H. Adler(WinnMed), Bastiaan R. Bloem(Radboud University Nijmegen), Glenda M. Halliday(The University of Sydney), Piu Chan(Capital Medical University), Werner Poewe(Innsbruck Medical University), Thomas Gasser(Hertie Institute for Clinical Brain Research), Günther Deuschl(Christian-Albrechts-Universität zu Kiel), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Lawrence Joseph(McGill University Health Centre), Anthony E. Lang(University of Toronto), Wolfgang H. Oertel(Philipps University of Marburg), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 147
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k